• Profile
Close

High-risk prescribing increases rates of new persistent opioid use in total hip arthroplasty patients

Journal of Arthroplasty Apr 20, 2020

Delaney LD, Gunaseelan V, Rieck H, et al. - Via conducting a retrospective analysis of Medicare claims in Michigan, researchers explored the connection between surgeon prescribing and new persistent use among total hip arthroplasty (THA) individuals. The study cohort comprised of orthopedic surgeons performing THAs from 2013-2016, and their opioid naïve patients, ages > 65. High-risk prescribing involved: high regular doses, overlapping prescriptions for benzodiazepine, concurrent opioid prescriptions, multi-provider prescriptions, or long-acting opioid prescriptions. Surgeons showed high-risk prescribing for 66% of encounters. The development of persistent opioid use after surgery is multifactorial, and the prescribing patterns of the surgeon play an important role. Reducing prescribing and encouraging opioid alternatives may reduce the persistent use of postoperative opioids.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay